Opportunity Information: Apply for PAR 15 146
Apply for PAR 15 146
- The National Institutes of Health in the environment health income security and social services sector is offering a public funding opportunity titled "Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.113 Environmental Health 93.846 Arthritis, Musculoskeletal and Skin Diseases Research 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders 93.865 Child Health and Human Development Extramural Research 93.867 Vision Research.
- This funding opportunity was created on Mar 19, 2015 and posted on Mar 19, 2015.
- Applicants must submit their applications by Sep 12, 2017. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts Others (see text field entitled Additional Information on Eligibility for clarification) Special district governments Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education State governments Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education County governments For profit organizations other than small businesses City or township governments Small businesses Public housing authorities/Indian housing authorities.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54) opportunity (Funding Opportunity Number PAR 15-146) is a National Institutes of Health (NIH) cooperative agreement designed to build multidisciplinary research centers focused on developing medical countermeasures for toxic chemical exposures. The program sits under the broader CounterACT mission to accelerate research and development of new or improved therapeutics for chemical threats, including agents that could be used deliberately (such as classic chemical warfare agents) and chemicals that may be encountered through accidents involving industrial production, storage, or transport (toxic industrial chemicals), as well as certain pesticides. In practical terms, NIH is looking to fund coordinated center-based efforts that can move promising ideas beyond basic discovery and into the kinds of translational studies that support real-world readiness and eventual advanced development.
The scientific scope is explicitly translational and spans a wide arc of product-focused R and D. Proposed work can start at target or candidate identification and characterization, move through optimization of candidate therapeutics, and extend through demonstration of in vivo efficacy. The FOA also allows progression into IND-enabling studies, meaning the types of preclinical packages typically required to support an Investigational New Drug application and prepare a therapy for later-stage development. This signals that NIH expects applicants to think in terms of deliverables, development pathways, and evidence thresholds, not just mechanistic insights. The emphasis is on therapies and countermeasures that can mitigate injury or improve outcomes following exposure to harmful chemicals, aligning the work with public health preparedness and emergency response needs.
Structurally, applicants must propose a full Center of Excellence rather than a single project. Each center is required to include at least three research projects, and those projects must be supported by both administrative and scientific cores. The administrative core generally provides leadership, governance, coordination, communications, and oversight across projects, while scientific cores provide shared resources, technologies, models, or specialized services that enable multiple projects to progress efficiently and consistently. In addition to these cores, the center must include a research education core, reflecting an expectation that the program will also help develop talent and expand the pipeline of researchers trained to work on chemical threat countermeasure development. The U54 mechanism is a cooperative agreement, which typically means NIH program staff will have substantial involvement in the funded effort through coordination, guidance, and stewardship consistent with the cooperative model, especially important for milestone-driven translational programs.
A defining feature of this FOA is the requirement that each research project include clear, milestone-based planning with discrete go or no-go decision points. This is meant to impose development discipline, ensuring projects have measurable endpoints, timelines, and objective criteria for continuation, redirection, or termination as evidence emerges. In other words, the agency is not just funding exploration; it is funding a staged translational plan where progress is continuously evaluated against pre-specified performance benchmarks. This approach is common in programs intended to push interventions toward practical deployment, because it helps manage risk and concentrates resources on candidates that meet defined thresholds.
From an administrative standpoint, the opportunity was posted March 19, 2015, with an original and current closing date of September 12, 2017, and an archive date of October 13, 2017. While that timing indicates the specific FOA is no longer accepting applications, the summary still matters as a model for how NIH structures CounterACT center funding and what it typically expects in terms of translational readiness, center infrastructure, and milestone rigor.
Eligibility is broad across U.S.-based entities and spans many institution types. Eligible applicants include state, county, city or township, and special district governments; public and state-controlled institutions of higher education; private institutions of higher education; nonprofit organizations with or without 501(c)(3) status (with the usual distinctions in NIH policy); for-profit organizations other than small businesses; and small businesses. Various Native American tribal governments and tribal organizations are included, and public housing authorities/Indian housing authorities are also listed. The FOA further clarifies that additional eligible applicants include Alaska Native and Native Hawaiian Serving Institutions; Asian American, Native American, and Pacific Islander Serving Institutions (AANAPISIs); Hispanic Serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs); faith-based or community-based organizations; regional organizations; eligible federal agencies; and U.S. territories or possessions. Foreign institutions (non-U.S. entities) are not eligible to apply, and non-U.S. components of U.S. organizations are not eligible; however, foreign components as defined by the NIH Grants Policy Statement are allowed, which typically means certain clearly justified international elements can be included when they add unique value and comply with NIH rules.
The opportunity is categorized as discretionary funding and uses the cooperative agreement instrument, with activity categories spanning environment, health, income security, and social services. It references multiple CFDA numbers associated with NIH research portfolios, including Environmental Health (93.113), arthritis/musculoskeletal/skin diseases research (93.846), extramural neuroscience and neurological disorders research (93.853), child health and human development extramural research (93.865), and vision research (93.867). No cost sharing or matching is required, which is typical for NIH research awards. For applicants and administrators, the official announcement was hosted through the NIH Grants Guide (linked in the source), and NIH provided contact points through the NIH Office of Extramural Research web support for access or linking issues.
Overall, this FOA supports integrated, milestone-driven centers that can take chemical threat countermeasure concepts from early identification through optimization and robust in vivo evidence, potentially reaching IND-enabling readiness. It combines coordinated multi-project science, shared infrastructure, and workforce development, with NIH actively involved through the cooperative agreement framework to keep the program aligned with translational objectives and preparedness-oriented outcomes.
Frequently Asked Questions (FAQs)
What is the CounterACT Research Centers of Excellence (U54) opportunity?
It is an NIH cooperative agreement funding opportunity (U54) intended to build multidisciplinary research centers focused on developing medical countermeasures for toxic chemical exposures. The specific opportunity described is the Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54), Funding Opportunity Number PAR 15-146.
What is the overall goal of the CounterACT program as described here?
The goal is to accelerate research and development of new or improved therapeutics to address chemical threats. This includes agents that could be used deliberately (for example, classic chemical warfare agents) as well as chemicals encountered through accidental industrial releases (toxic industrial chemicals) and certain pesticides.
What kinds of threats and chemicals are within scope?
The scope includes harmful chemical exposures from deliberate use (such as chemical warfare agents), accidental exposure related to industrial production, storage, or transport (toxic industrial chemicals), and certain pesticides.
What type of work is NIH looking to support under this FOA?
The FOA emphasizes translational, product-focused research and development. The intent is to move promising concepts beyond basic discovery into translational studies that support real-world readiness and eventual advanced development.
How translational is the expected scientific scope?
The scope is explicitly translational and spans a wide arc of development activities, including target or candidate identification and characterization, optimization of candidate therapeutics, and demonstration of in vivo efficacy. The FOA also allows progression into IND-enabling studies.
What does it mean that the FOA allows IND-enabling studies?
It means proposed projects may include the types of preclinical study packages typically needed to support an Investigational New Drug (IND) application and to prepare a therapy for later-stage development. This signals an expectation for planning around development pathways, deliverables, and evidence thresholds.
What kinds of outcomes or impacts is the program aiming for?
The emphasis is on therapies and countermeasures that can mitigate injury or improve outcomes following exposure to harmful chemicals, aligning the work with public health preparedness and emergency response needs.
Is this a single-project grant or a center-based grant?
It is a center-based award. Applicants must propose a full Center of Excellence rather than a single project.
How many research projects must a proposed center include?
Each center is required to include at least three research projects.
What cores are required within the center?
The center must be supported by both an administrative core and scientific cores. In addition, a research education core is required.
What is the role of the administrative core?
The administrative core generally provides leadership, governance, coordination, communications, and oversight across the center and its projects.
What is the role of scientific cores?
Scientific cores provide shared resources, technologies, models, or specialized services that enable multiple projects to progress efficiently and consistently.
What is the research education core and why is it required?
The research education core reflects an expectation that the center will help develop talent and expand the pipeline of researchers trained to work on chemical threat countermeasure development.
What does the U54 cooperative agreement mechanism imply?
The U54 here is described as a cooperative agreement, which typically means NIH program staff will have substantial involvement in the funded effort through coordination, guidance, and stewardship consistent with the cooperative model, particularly for milestone-driven translational programs.
Are milestones required for the research projects?
Yes. A defining feature of the FOA is the requirement that each research project include clear, milestone-based planning.
What are "go/no-go" decision points in this context?
They are discrete decision points tied to measurable milestones and objective criteria. These points are intended to determine whether a project should continue as planned, be redirected, or be terminated based on the evidence generated.
Why does the FOA emphasize milestone rigor?
The milestone approach is meant to impose development discipline, with measurable endpoints, timelines, and objective continuation criteria. This helps manage risk and focus resources on candidates that meet defined thresholds in a staged translational plan.
When was this opportunity posted, and what were the key dates?
The opportunity was posted March 19, 2015. The original and current closing date listed was September 12, 2017, and the archive date was October 13, 2017.
Is PAR 15-146 still accepting applications?
No. Based on the provided dates (closing date September 12, 2017 and archive date October 13, 2017), the specific FOA described is no longer accepting applications.
Why might this archived FOA still be useful to review?
The summary can serve as a model for how NIH structures CounterACT center funding and what it expects regarding translational readiness, required center infrastructure (projects and cores), and milestone-based management.
Who is eligible to apply (in general terms)?
Eligibility is broad across U.S.-based entities and includes many types of governments, higher education institutions, nonprofit and for-profit organizations (with specified limits), small businesses, tribal entities, public housing authorities/Indian housing authorities, eligible federal agencies, and U.S. territories or possessions.
Which government entities are eligible?
Eligible applicants include state, county, city or township, and special district governments.
Are colleges and universities eligible?
Yes. Public and state-controlled institutions of higher education as well as private institutions of higher education are included as eligible applicants.
Are nonprofit organizations eligible?
Yes. Nonprofit organizations with or without 501(c)(3) status are listed as eligible (subject to the usual NIH policy distinctions referenced in the description).
Are for-profit organizations eligible?
Yes. For-profit organizations other than small businesses are listed as eligible, and small businesses are also listed as eligible.
Are tribal governments and tribal organizations eligible?
Yes. Various Native American tribal governments and tribal organizations are included as eligible applicants.
Are U.S. territories or possessions eligible to apply?
Yes. U.S. territories or possessions are listed among eligible applicants.
Are foreign (non-U.S.) institutions eligible to apply as the applicant organization?
No. Foreign institutions (non-U.S. entities) are not eligible to apply.
Can a U.S. organization include non-U.S. components?
No. Non-U.S. components of U.S. organizations are not eligible, as stated in the provided description.
Are any international elements allowed at all?
Yes. Foreign components, as defined by the NIH Grants Policy Statement, are allowed when they add unique value and comply with NIH rules (as characterized in the provided information).
Does this opportunity require cost sharing or matching funds?
No. No cost sharing or matching is required.
What type of funding is this categorized as?
It is categorized as discretionary funding and uses the cooperative agreement instrument.
What activity categories are associated with this opportunity?
The activity categories are described as spanning environment, health, income security, and social services.
Which CFDA numbers are referenced?
The description references multiple CFDA numbers associated with NIH research portfolios: Environmental Health (93.113), arthritis/musculoskeletal/skin diseases research (93.846), extramural neuroscience and neurological disorders research (93.853), child health and human development extramural research (93.865), and vision research (93.867).
Where was the official announcement hosted?
The official announcement was hosted through the NIH Grants Guide (as referenced in the source description).
Where were applicants directed for access or linking support?
NIH provided contact points through the NIH Office of Extramural Research web support for access or linking issues.
Browse more opportunities from the same category: Environment Health Income Security and Social Services
Next opportunity: 0 Master Cooperative Agreement
Previous opportunity: Special Research Grants Program Potato Breeding Research
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 15 146
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 15 146) also looked into and applied for these:
| Funding Opportunity |
|---|
| Countermeasures Against Chemical Threats (CounterACT) Exploratory/Developmental Projects in Translational Research (R21) Apply for PAR 15 315 Funding Number: PAR 15 315 Agency: National Institutes of Health Category: Environment Health Income Security and Social Services Funding Amount: Case Dependent |
| Genetic Susceptibility and Variability of Human Structural Birth Defects (R01) Apply for PA 08 011 Funding Number: PA 08 011 Agency: National Institutes of Health Category: Environment Health Income Security and Social Services Funding Amount: Case Dependent |
| Developmental Pharmacology (R03) Apply for PAR 08 215 Funding Number: PAR 08 215 Agency: National Institutes of Health Category: Environment Health Income Security and Social Services Funding Amount: Case Dependent |
| Developmental Pharmacology (R21) Apply for PAR 08 216 Funding Number: PAR 08 216 Agency: National Institutes of Health Category: Environment Health Income Security and Social Services Funding Amount: $200,000 |
| Genetic and Genomic Analysis of Xenopus (R01) Apply for PAR 09 240 Funding Number: PAR 09 240 Agency: National Institutes of Health Category: Environment Health Income Security and Social Services Funding Amount: Case Dependent |
| Genetic and Genomic Analysis of Xenopus (R21) Apply for PAR 09 241 Funding Number: PAR 09 241 Agency: National Institutes of Health Category: Environment Health Income Security and Social Services Funding Amount: $200,000 |
| Countermeasures Against Chemical Threats (CounterACT) Cooperative Research Projects (U01) Apply for PAR 10 180 Funding Number: PAR 10 180 Agency: National Institutes of Health Category: Environment Health Income Security and Social Services Funding Amount: Case Dependent |
| Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54) Apply for PAR 10 181 Funding Number: PAR 10 181 Agency: National Institutes of Health Category: Environment Health Income Security and Social Services Funding Amount: Case Dependent |
| Developmental Pharmacology (R01) Apply for PAR 11 057 Funding Number: PAR 11 057 Agency: National Institutes of Health Category: Environment Health Income Security and Social Services Funding Amount: $499,999 |
| Developmental Pharmacology (R03) Apply for PAR 11 058 Funding Number: PAR 11 058 Agency: National Institutes of Health Category: Environment Health Income Security and Social Services Funding Amount: $50,000 |
| Developmental Pharmacology (R21) Apply for PAR 11 059 Funding Number: PAR 11 059 Agency: National Institutes of Health Category: Environment Health Income Security and Social Services Funding Amount: $200,000 |
| Countermeasures Against Chemical Threats (CounterACT) Cooperative Research Projects (U01) Apply for PAR 11 155 Funding Number: PAR 11 155 Agency: National Institutes of Health Category: Environment Health Income Security and Social Services Funding Amount: Case Dependent |
| Autism Centers of Excellence Centers (P50) Apply for RFA HD 12 195 Funding Number: RFA HD 12 195 Agency: National Institutes of Health Category: Environment Health Income Security and Social Services Funding Amount: $1,500,000 |
| Autism Centers of Excellence Networks (R01) Apply for RFA HD 12 196 Funding Number: RFA HD 12 196 Agency: National Institutes of Health Category: Environment Health Income Security and Social Services Funding Amount: $2,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 15 146", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
